1. Home
  2. CAL vs CCCC Comparison

CAL vs CCCC Comparison

Compare CAL & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caleres Inc.

CAL

Caleres Inc.

HOLD

Current Price

$12.45

Market Cap

432.0M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

SELL

Current Price

$2.86

Market Cap

404.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CAL
CCCC
Founded
1878
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
432.0M
404.7M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
CAL
CCCC
Price
$12.45
$2.86
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
★ $17.00
$13.33
AVG Volume (30 Days)
539.7K
★ 1.9M
Earning Date
09-09-2026
11-05-2026
Dividend Yield
★ 2.29%
N/A
EPS Growth
N/A
★ 16.45
EPS
★ 2.14
N/A
Revenue
★ $85,513,000.00
$35,947,000.00
Revenue This Year
$3.87
N/A
Revenue Next Year
$2.84
N/A
P/E Ratio
$5.72
★ N/A
Revenue Growth
0.46
★ 1.02
52 Week Low
$8.80
$1.69
52 Week High
$15.04
$5.17

Technical Indicators

Market Signals
Indicator
CAL
CCCC
Relative Strength Index (RSI) 49.95 31.02
Support Level $12.02 $2.52
Resistance Level $14.20 $3.91
Average True Range (ATR) 0.50 0.20
MACD 0.04 -0.02
Stochastic Oscillator 69.11 1.92

Price Performance

Historical Comparison
CAL
CCCC

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - Famous Footwear and Brand Portfolio. The Famous Footwear segment is comprised of its Famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. This segment is comprised of wholesale operations that designs, develops, sources, manufactures, markets and distributes branded, licensed and private-label footwear. Geographically, the company generates the majority of its revenue from Domestic operations.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: